Total Payments
$16,856
2024 Payments
$2,975
Companies
54
Transactions
594
Medicare Patients
2,702
Medicare Billing
$198,632
Payment Breakdown by Category
Food & Beverage$15,236 (90.4%)
Travel$1,386 (8.2%)
Education$122.33 (0.7%)
Other$110.70 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,236 | 587 | 90.4% |
| Travel and Lodging | $1,386 | 4 | 8.2% |
| Education | $122.33 | 2 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110.70 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,258 | 101 | $0 (2024) |
| Novo Nordisk Inc | $2,306 | 126 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $1,629 | 8 | $0 (2019) |
| GlaxoSmithKline, LLC. | $865.42 | 48 | $0 (2024) |
| Lilly USA, LLC | $831.78 | 38 | $0 (2024) |
| Amgen Inc. | $797.42 | 25 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $653.11 | 8 | $0 (2023) |
| Abbott Laboratories | $482.87 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $471.52 | 8 | $0 (2023) |
| Dexcom, Inc. | $451.24 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,975 | 87 | AstraZeneca Pharmaceuticals LP ($1,185) |
| 2023 | $3,214 | 107 | AstraZeneca Pharmaceuticals LP ($789.80) |
| 2022 | $3,394 | 120 | Novo Nordisk Inc ($592.38) |
| 2021 | $1,510 | 50 | AstraZeneca Pharmaceuticals LP ($330.39) |
| 2020 | $102.22 | 2 | Ethicon US, LLC ($69.95) |
| 2019 | $982.47 | 6 | W. L. Gore & Associates, Inc. ($950.44) |
| 2018 | $3,132 | 135 | W. L. Gore & Associates, Inc. ($678.38) |
| 2017 | $1,545 | 87 | Novo Nordisk Inc ($393.91) |
All Payment Transactions
594 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $90.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.50 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Respiratory | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.71 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 575 | 1,083 | $134,469 | $52,758 |
| 2022 | 9 | 565 | 1,167 | $112,392 | $53,740 |
| 2021 | 11 | 799 | 1,507 | $175,152 | $55,739 |
| 2020 | 13 | 763 | 1,343 | $139,425 | $36,395 |
Total Patients
2,702
Total Services
5,100
Medicare Billing
$198,632
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 333 | $67,969 | $27,922 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 133 | $24,331 | $7,987 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $8,100 | $3,850 | 47.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 71 | $7,070 | $3,571 | 50.5% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 68 | 68 | $10,200 | $2,415 | 23.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 18 | 72 | $8,064 | $2,284 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 136 | 293 | $2,344 | $2,233 | 95.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 35 | $3,500 | $1,353 | 38.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 19 | $1,520 | $814.97 | 53.6% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 14 | 14 | $546.00 | $220.50 | 40.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $825.00 | $108.00 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 475 | $86,321 | $41,551 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 111 | $16,797 | $7,537 | 44.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 21 | 21 | $1,965 | $1,327 | 67.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 167 | 369 | $2,952 | $1,072 | 36.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 21 | $1,600 | $903.32 | 56.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $770.00 | $625.23 | 81.2% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 59 | 105 | $327.00 | $309.86 | 94.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 25 | 28 | $1,540 | $296.72 | 19.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 15 | 15 | $120.00 | $118.80 | 99.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 179 | 424 | $115,928 | $36,862 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 151 | $28,086 | $9,257 | 33.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 29 | $10,701 | $3,230 | 30.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 82 | 158 | $5,214 | $1,534 | 29.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 21 | 21 | $2,814 | $1,370 | 48.7% |
About Dr. David Williams, MD
Dr. David Williams, MD is a Internal Medicine healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1710022017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Williams, MD has received a total of $16,856 in payments from pharmaceutical and medical device companies, with $2,975 received in 2024. These payments were reported across 594 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($15,236).
As a Medicare-enrolled provider, Williams has provided services to 2,702 Medicare beneficiaries, totaling 5,100 services with total Medicare billing of $198,632. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Southfield, MI
- Active Since 02/21/2007
- Last Updated 05/13/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1710022017
Products in Payments
- TAG Thoracic Endoprosthesis (Device) $1,629
- FARXIGA (Drug) $1,253
- BREZTRI (Drug) $906.37
- Ozempic (Drug) $611.64
- Rybelsus (Drug) $554.22
- Victoza (Drug) $528.81
- TRELEGY ELLIPTA (Drug) $509.23
- Repatha (Biological) $499.62
- MOUNJARO (Drug) $413.96
- FASENRA (Biological) $401.26
- Kerendia (Drug) $400.25
- ENTRESTO (Drug) $373.28
- DUPIXENT (Biological) $366.59
- AIRSUPRA (Drug) $332.92
- GEMTESA (Drug) $281.50
- AUSTEDO (Drug) $244.01
- MYRBETRIQ (Drug) $243.36
- ELIQUIS (Drug) $228.93
- XARELTO (Drug) $227.06
- Otezla (Drug) $219.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Southfield
Adam Forman, Md, MD
Internal Medicine — Payments: $380,039
Internal Medicine $380,039
Dr. Christopher Bradley, D.o, D.O
Internal Medicine — Payments: $88,030
Internal Medicine $88,030
Dr. Fouad Batah, M.d, M.D
Internal Medicine — Payments: $24,345
Internal Medicine $24,345
Dr. Jeffrey Najor, M.d, M.D
Internal Medicine — Payments: $18,970
Internal Medicine $18,970
Stephen Lynch, M.d, M.D
Internal Medicine — Payments: $17,912
Internal Medicine $17,912
Richard Stober, Md, MD
Internal Medicine — Payments: $14,724
Internal Medicine $14,724